Iran Healthcare and Medicine Tenders

Market size: Estimated at US$40 billion in 2023, projected to reach US$60 billion by 2027.
Growth drivers: Aging population, rising disposable incomes, government focus on healthcare expansion.
Key areas: Pharmaceuticals, medical devices, diagnostics, medical tourism.

Budget allocation: Over 10% of national budget dedicated to healthcare.
Procurement channels: Direct purchases, tenders, long-term contracts.
Transparency: Efforts underway to improve visibility and efficiency.

Pharmaceuticals: Generic drugs, specialty medicines, vaccines.
Medical devices: Imaging equipment, surgical instruments, prosthetics.
Diagnostics: Lab tests, genetic analysis, telemedicine solutions.
Medical tourism: Cosmetic surgery, fertility treatments, dental care.

Ministry of Health and Medical Education (MOHME): Sets policies, oversees procurement.
Food and Drug Administration (FDA): Regulates pharmaceuticals and devices.
State Health Insurance Organization (SHIO): Manages healthcare financing.

Domestic: Giants like OOO Gemat and NPF Medtep hold fort, boasting extensive production lines. They often secure deals for everything from locally-produced pharmaceuticals to diagnostic equipment, ensuring the accessibility of basic healthcare needs.
International: Global heavyweights like Siemens and Philips still win contracts for high-tech imaging equipment and advanced medical devices.

Tags -
Iran healthcare medicine tenders, free Iran healthcare medicine tenders, government healthcare medicine tenders Iran, Iran Hospital supply tenders, Iran healthcare consultancy tenders, Iran medicine tenders, Iran hospital tenders, Iran drugs tenders, Iran health services tenders